LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3 asthma patients

Sunny Jabbal (Dundee, United Kingdom), Sunny Jabbal, Arvind Manoharan, William Anderson, Joseph Lipworth, Brian Lipworth

Source: International Congress 2016 – Novel strategies on COPD and asthma management
Session: Novel strategies on COPD and asthma management
Session type: Oral Presentation
Number: 4829
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sunny Jabbal (Dundee, United Kingdom), Sunny Jabbal, Arvind Manoharan, William Anderson, Joseph Lipworth, Brian Lipworth. LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3 asthma patients. Eur Respir J 2016; 48: Suppl. 60, 4829

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016



LATE-BREAKING ABSTRACT: Lung function assessed by home forced oscillation and self reported symptoms during COPD exacerbations
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

LATE-BREAKING ABSTRACT: A useful physiological marker for evaluating the effect of indacaterol in COPD patients.
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013


LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013

LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016


The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

LATE-BREAKING ABSTRACT: Is treatment with inhaled corticosteroids in asthma associated with hospitalisations because of pneumonia?
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013



LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial.
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

LATE-BREAKING ABSTRACT: Predicting asthma at age 8; the application of machine learning
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016

A "real life" study on height in prebupertal asthmatic children receiving inhaled steroids
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


LATE-BREAKING ABSTRACT: LAVOLTA I and II: Results of 2 phase III studies to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016


LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



LATE-BREAKING ABSTRACT: The analysis of the severe asthma prevalence rate in China
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016


LATE-BREAKING ABSTRACT: A 2 year follow up randomized pilot study of a care on demand system in COPD patients.
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013

LATE-BREAKING ABSTRACT: Systematic review and meta-analysis of the magnitude of the effect on AQLQ and ACQ in asthma clinical trials
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013


Effectiveness evaluation of anti-IgE treatment at 3rd year: Real life Turkey data
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013